ECONOMY AND DIGITAL TRANSFORMATION IMPACTING HEALTHCARE COMPANIES

NAICU Carmen, Novartis

SERBU Sorin Razvan, Lucian Blaga University of Sibiu, Romania

Abstract:
Traditional model of developing drugs was slow and very expensive, relying on the face to face interactions only. In the meantime, increasing numbers of new molecules that are studied in clinical trials to become drugs required more and more investment, which derived to a reduced reimbursement. What if the patients can benefit more on the digital medicine and treating chronic diseases on digital medicine but also some of the acute symptoms? The aim of research, was to evaluate the impact on the companies reimbursement of “GO Digital” alternatives as well as the impact of patient’s life quality

Keywords: digitalization, e-health, m-heath

JEL Classification: I15, O33

Volume: 72, Issue: 3

Pages: 66 - 74

Publication date: November, 2020

Download the article: http://economice.ulbsibiu.ro/revista.economica/archive/72306naicu&serbu.pdf

”Cite